HRMY (STOCKS)
Harmony Biosciences Holdings, Inc. Common Stock
$29.050000
+0.160000 (+0.55%)
Prev close: $28.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jeffrey M. Dayno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,679.69M
- Employees
- 268
- P/E (TTM)
- 10.66
- P/B (TTM)
- 1.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.38 | $0.91 | -0.5344 | -58.44% |
|
Sep 2025 (Q3)
|
$0.87 | $0.86 | +0.0139 | +1.62% |
|
Jun 2025 (Q2)
|
$0.68 | $0.77 | -0.0855 | -11.17% |
|
Mar 2025 (Q1)
|
$0.78 | $0.60 | +0.1846 | +31.00% |
Financial Statements
| Revenues | $868.45M |
| Benefits Costs and Expenses | $653.39M |
| Cost Of Revenue | $198.34M |
| Costs And Expenses | $653.39M |
| Gross Profit | $670.11M |
| Operating Expenses | $461.64M |
| Research and Development | $189.59M |
| Other Operating Expenses | $272.05M |
| Operating Income/Loss | $208.47M |
| Income/Loss From Continuing Operations After Tax | $158.69M |
| Income/Loss From Continuing Operations Before Tax | $215.06M |
| Income Tax Expense/Benefit | $56.38M |
| Income Tax Expense/Benefit, Current | $15.68M |
| Income Tax Expense/Benefit, Deferred | $40.70M |
| Net Income/Loss | $158.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $158.69M |
| Net Income/Loss Available To Common Stockholders, Basic | $158.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.76 |
| Diluted Earnings Per Share | $2.71 |
| Basic Average Shares | 57,492,277 |
| Diluted Average Shares | 58,544,570 |
| Assets | $1.27B |
| Current Assets | $907.01M |
| Inventory | $5.36M |
| Prepaid Expenses | $16.01M |
| Other Current Assets | $885.64M |
| Noncurrent Assets | $364.62M |
| Intangible Assets | $89.42M |
| Other Non-current Assets | $275.20M |
| Liabilities | $401.41M |
| Current Liabilities | $252.13M |
| Accounts Payable | $17.69M |
| Wages | $18.44M |
| Other Current Liabilities | $216.00M |
| Noncurrent Liabilities | $149.28M |
| Long-term Debt | $163.66M |
| Equity | $870.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $870.22M |
| Liabilities And Equity | $1.27B |
| Net Cash Flow From Operating Activities | $348.20M |
| Net Cash Flow From Operating Activities, Continuing | $348.20M |
| Net Cash Flow From Investing Activities | -$39.65M |
| Net Cash Flow From Investing Activities, Continuing | -$39.65M |
| Net Cash Flow From Financing Activities | -$9.05M |
| Net Cash Flow From Financing Activities, Continuing | -$9.05M |
| Net Cash Flow | $299.50M |
| Net Cash Flow, Continuing | $299.50M |
| Comprehensive Income/Loss | $158.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $158.97M |
| Other Comprehensive Income/Loss | $280.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $280.00K |